This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Jasper J. Quak, MD, PhD; Martijn Gerretsen, MS; Ad H. G. J. Schrijvers, PhD; Chris J. L. M. Meijer, MD, PhD; Guus A. M. S. van Dongen, PhD; Gordan B. Snow, MD, PhD

Arch Otolaryngol Head Neck Surg. 1991;117(11):1287-1291.

Abstract
• We recently produced the monoclonal antibody E48 as a specific reagent for squamous cell carcinomas. In our ongoing investigations to use E48 for clinical tumor detection and therapy, fundamental aspects of the antigen have to be elucidated and practical applications of the antibody have to be tested in a preclinical model. Immunoelectron-microscopic studies localized the E48 antigen along the cell surface and in between desmosomes, suggesting that the antigen serves as an adhesion molecule. To evaluate the usefulness of E48 for radioimmunodetection of neck node metastases, nodes from 20 neck dissection specimens were tested. A strong reactivity was observed. Furthermore, F(ab')₂ fragments of E48 were compared with the complete IgG E48 for selective tumor detection in an animal model. It was demonstrated that E48 F(ab')₂ fragments localize faster and reach higher tumor-nontumor ratios than the whole molecule.

(Arch Otolaryngol Head Neck Surg. 1991;117:1287-1291)

Author Affiliations
From the Departments of Head and Neck Surgery—Otolaryngology (Drs Quak, Gerretsen, Schrijvers, van Dongen, and Snow) and Pathology (Dr Meijer), the Free University Hospital, Amsterdam, the Netherlands.

Footnotes
Accepted for publication March 13, 1991.

Presented at the American Society of Head and Neck Surgeons meeting, Palm Beach, Fla, April 30, 1990.

Reprints not available.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?